CIPRODEX is a Auricular (otic) Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Ciprofloxacin Hydrochloride; Dexamethasone.
Product ID | 0065-8533_7f9e10f3-fa47-46ad-a689-1190f09714d2 |
NDC | 0065-8533 |
Product Type | Human Prescription Drug |
Proprietary Name | CIPRODEX |
Generic Name | Ciprofloxacin And Dexamethasone |
Dosage Form | Suspension/ Drops |
Route of Administration | AURICULAR (OTIC) |
Marketing Start Date | 2003-08-04 |
Marketing Category | NDA / NDA |
Application Number | NDA021537 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2003-08-04 |
Marketing End Date | 2021-11-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021537 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2003-08-04 |
Marketing Category | NDA |
Application Number | NDA021537 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2003-08-04 |
Marketing Category | NDA |
Application Number | NDA021537 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2003-08-04 |
Marketing End Date | 2011-07-11 |
Marketing Category | NDA |
Application Number | NDA021537 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2003-08-04 |
Marketing Category | NDA |
Application Number | NDA021537 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-05-19 |
Ingredient | Strength |
---|---|
CIPROFLOXACIN HYDROCHLORIDE | 3 mg/mL |
SPL SET ID: | 0ed518de-4ae1-43d1-84ff-26872d9e6a0f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0065-8533 | CIPRODEX | ciprofloxacin and dexamethasone |
0078-0799 | CIPRODEX | ciprofloxacin and dexamethasone |
21695-969 | CIPRODEX | ciprofloxacin and dexamethasone |
68071-1629 | CIPRODEX | ciprofloxacin and dexamethasone |
71205-309 | CIPRODEX | ciprofloxacin and dexamethasone |
0781-6186 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone |
16714-628 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone |
43598-326 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone |
62756-427 | Ciprofloxacin and dexamethasone | Ciprofloxacin and dexamethasone |
63629-8797 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CIPRODEX 75935885 2513415 Live/Registered |
Bayer Aktiengesellschaft 2000-03-06 |